(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclopentylacetic acid, 95.0%, 1g

(1-Ethylpiperidin-4-yl)methanamine dihydrochloride, 1g

Sodium (S)-6-methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-1701, 50 m, 0,25 mm, 0,25 µm, 1 pièce(s)

4-Amino-N-(tert-butoxycarbonyl)-L-phenylalanine>96.0%(HPLC)(T)5g

3-[(4-nitro-1H-pyrazol-1-yl)methyl]benzonitrile, 95.0%, 1g

5-Fluoro-4-methyl-2-nitrophenol, 95.0%, 250mg

n-[3-(benzyloxy)pyridin-2-yl]benzenesulfonamide, 98%, 50mg

1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborole-6-carboxylic acid, 97%, 5g

N-Fmoc-2,5-difluoro-L-phenylalanine, 98%, 5g

3-(3-thienyl)propanoic acid, 95.0%, 2.5g

(4-Chloro-phthalazin-1-yl)-methyl-amine, 95.0%, 250mg

3-(4-Phenoxyphenyl)propionic acid, 98.0%, 1g